% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • paris1785 paris1785 Dec 19, 2013 2:38 PM Flag

    Is there an elephant in the room

    Nobody has mentioned it, and it is a Machiavellian twist, but one party that could lose if new expensive drugs get approved early (especially if they are later shown ineffective) is health insurers.
    just wondering what their lobbyists are saying about FDASIA and potential "new" FDA. Opposite argument is that saving people's health saves money in the long run, but who the heck knows.
    Just wondering what countervailing forces exist to the logic of FDASIA and getting new drugs to market faster.

    The other answer is that big pharma has a huge "moat" around its products due to the $billion drug approval process. If little companies can get drugs approved quickly at low cost, ultimately lowering drug/patient cost, curing illness more cheaply, it will hurt the existing oligopolistic pharma industry leaders.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • IN reality I think the cost of the drug over a life time is probably less than caring for these kids during natural progression. Money is the reason but its GSK/RNA and the big three charities that have the most to lose

    • paris1785, you're pushing the write button - MONEY. Are we talking CRIME? Parents are advised to contact the '48 Hours'.
      The following is from Google:
      '48 Hours is an American documentary television series that airs on CBS. The series has been broadcast on the network since January 19, 1988.
      The series airs Saturday nights at 10 p.m. (Eastern and Pacific time)/9 p.m. (Central and Mountain time) as part of the network's placeholder Crimetime Saturday block; as such, the series is currently one of only two remaining first-run prime time programs (excluding sports) airing Saturdays on the major U.S. broadcast television networks, along with Univision's Sabado Gigante. The program sometimes airs two-hour episodes or two episodes in a row on Saturday night depending on the subject involved or to counterprogram other networks'

26.78+1.02(+3.96%)Aug 26 4:00 PMEDT